CA1320730C
(en)
*
|
1987-10-16 |
1993-07-27 |
The Du Pont Merck Pharmaceutical Company |
Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
|
US5231188A
(en)
*
|
1989-11-17 |
1993-07-27 |
The Upjohn Company |
Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
|
JP3176626B2
(ja)
*
|
1991-11-01 |
2001-06-18 |
ファルマシア・アンド・アップジョン・カンパニー |
抗菌剤として有用な置換アリール−およびヘテロアリールフェニルオキサゾリジノン類
|
SK283420B6
(sk)
*
|
1992-05-08 |
2003-07-01 |
Pharmacia & Upjohn Company |
Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
|
RU2119484C1
(ru)
*
|
1992-12-08 |
1998-09-27 |
Дзе Апджон Компани |
Тропонзамещенный фенилоксазолидинон или его фармацевтически приемлемые соли или гидраты
|
MY115155A
(en)
*
|
1993-09-09 |
2003-04-30 |
Upjohn Co |
Substituted oxazine and thiazine oxazolidinone antimicrobials.
|
US5688792A
(en)
*
|
1994-08-16 |
1997-11-18 |
Pharmacia & Upjohn Company |
Substituted oxazine and thiazine oxazolidinone antimicrobials
|
DK0730591T3
(da)
*
|
1993-11-22 |
2000-01-31 |
Upjohn Co |
Estere af substituerede hydroxyacetyl-piperazin-phenyl-oxazolidinoner
|
US5668286A
(en)
*
|
1994-03-15 |
1997-09-16 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions containing them
|
JPH0873455A
(ja)
*
|
1994-03-15 |
1996-03-19 |
Upjohn Co:The |
オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
|
DE4425613A1
(de)
*
|
1994-07-20 |
1996-01-25 |
Bayer Ag |
5-gliedrige Heteroaryl-oxazolidinone
|
DE4425612A1
(de)
*
|
1994-07-20 |
1996-04-04 |
Bayer Ag |
6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
|
SK282869B6
(sk)
*
|
1994-10-26 |
2003-01-09 |
Pharmacia + Upjohn Company |
Antimikrobiálne fenyloxazolidinóny
|
DK0710657T3
(da)
*
|
1994-11-02 |
1999-05-25 |
Merck Patent Gmbh |
Adhæsionsreceptor-antagonister
|
WO1996015130A1
(en)
*
|
1994-11-15 |
1996-05-23 |
Pharmacia + Upjohn Company |
Bicyclic oxazine and thiazine oxazolidinone antibacterials
|
US6696459B1
(en)
|
1994-12-22 |
2004-02-24 |
Ligand Pharmaceuticals Inc. |
Steroid receptor modulator compounds and methods
|
US5696133A
(en)
|
1994-12-22 |
1997-12-09 |
Ligand Pharmaceuticals Incorporated |
Steroid receptor modulator compounds and methods
|
CN1075073C
(zh)
*
|
1995-02-03 |
2001-11-21 |
法玛西雅厄普约翰美国公司 |
杂芳环取代的苯基噁唑烷酮抗菌剂
|
CA2218088A1
(en)
*
|
1995-05-11 |
1996-11-14 |
Pharmacia & Upjohn Company |
Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
|
BR9610474A
(pt)
*
|
1995-09-01 |
1999-03-02 |
Upjohn Co |
Feniloxazolidinonas tendo uma ligação c-c a anéis heterocíclicos com 4-8 membros
|
MX9703040A
(es)
*
|
1995-09-12 |
1997-07-31 |
Upjohn Co |
Antimicrobianos de feniloxazolidinona.
|
GB9601666D0
(en)
*
|
1996-01-27 |
1996-03-27 |
Zeneca Ltd |
Chemical compounds
|
HRP970049A2
(en)
*
|
1996-02-06 |
1998-04-30 |
Bayer Ag |
New heteroaryl oxazolidinones
|
DE19604223A1
(de)
*
|
1996-02-06 |
1997-08-07 |
Bayer Ag |
Neue substituierte Oxazolidinone
|
GB9702213D0
(en)
*
|
1996-02-24 |
1997-03-26 |
Zeneca Ltd |
Chemical compounds
|
MY116093A
(en)
*
|
1996-02-26 |
2003-11-28 |
Upjohn Co |
Azolyl piperazinyl phenyl oxazolidinone antimicrobials
|
GB9604301D0
(en)
*
|
1996-02-29 |
1996-05-01 |
Zeneca Ltd |
Chemical compounds
|
ES2166073T3
(es)
*
|
1996-04-11 |
2002-04-01 |
Upjohn Co |
Procedimiento para preparar oxazolidinonas.
|
GB9609919D0
(en)
*
|
1996-05-11 |
1996-07-17 |
Zeneca Ltd |
Chemical compounds
|
EP0920421B1
(en)
*
|
1996-08-21 |
2002-11-06 |
PHARMACIA & UPJOHN COMPANY |
Isoxazoline derivatives useful as antimicrobials
|
US6218413B1
(en)
|
1997-05-30 |
2001-04-17 |
Pharmacia & Upjohn Company |
Oxazolidinone antibacterial agents having a thiocarbonyl functionality
|
US6255304B1
(en)
|
1997-05-30 |
2001-07-03 |
Pharmacia & Upjohn Company |
Oxazolidinone antibacterial agents having a thiocarbonyl functionality
|
CA2294293A1
(en)
*
|
1997-07-11 |
1999-01-21 |
Pharmacia & Upjohn Company |
Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents
|
GB9717807D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
CN100387581C
(zh)
|
1997-11-07 |
2008-05-14 |
法玛西雅厄普约翰美国公司 |
制备唑烷酮的方法
|
AU739055B2
(en)
*
|
1997-11-12 |
2001-10-04 |
Pharmacia & Upjohn Company |
Oxazolidinone derivatives and pharmaceutical compositions
|
GB9725244D0
(en)
*
|
1997-11-29 |
1998-01-28 |
Zeneca Ltd |
Chemical compounds
|
US6083967A
(en)
|
1997-12-05 |
2000-07-04 |
Pharmacia & Upjohn Company |
S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
KR20010015910A
(ko)
|
1998-01-23 |
2001-02-26 |
로렌스 티. 마이젠헬더 |
옥사졸리디논 조합 라이브러리, 조성물 및 제조 방법
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
ATE222894T1
(de)
*
|
1998-02-13 |
2002-09-15 |
Upjohn Co |
Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
|
KR20010052615A
(ko)
|
1998-06-05 |
2001-06-25 |
다비드 에 질레스 |
옥사졸리디논 유도체, 이것의 제조 방법 및 이것을함유하는 약학 조성물
|
US6420349B1
(en)
|
1998-08-24 |
2002-07-16 |
Bristol-Myers Squibb Company |
Isoxazolinone antibacterial agents
|
AU1379900A
(en)
*
|
1998-11-17 |
2000-06-05 |
Bayer Aktiengesellschaft |
Novel substituted phenyloxazolidone derivatives
|
WO2000045177A1
(en)
|
1999-01-27 |
2000-08-03 |
Pharmacia & Upjohn Company |
Assays for modulators of elongation factor p activity
|
KR100333493B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 카르보닐 옥사졸리디논 유도체 및 이의 제조방법
|
KR100333492B1
(ko)
*
|
1999-05-27 |
2002-04-25 |
박호군 |
이소옥사졸릴 메틸렌 옥사졸리디논 유도체 및 이의 제조방법
|
MXPA02000985A
(es)
*
|
1999-07-28 |
2002-07-30 |
Upjohn Co |
Oxazolidinonas y su uso como antiinfecciosos.
|
ATE337002T1
(de)
*
|
1999-09-13 |
2006-09-15 |
Insite Vision Inc |
Topische behandlung zur vorbeugung von augeninfektionen
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
US6451345B1
(en)
*
|
2000-01-20 |
2002-09-17 |
Eurand Pharmaceuticals Ltd. |
Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
|
GB0009803D0
(en)
*
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
KR100731469B1
(ko)
*
|
2000-06-05 |
2007-06-21 |
동아제약주식회사 |
피리딘 고리를 포함하는 옥사졸리디논 유도체 및 그의제조방법
|
US6465456B2
(en)
|
2000-06-29 |
2002-10-15 |
Bristol-Myers Squibb Company |
Isoxazolinone antibacterial agents
|
CA2415965A1
(en)
|
2000-07-17 |
2002-01-24 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
ATE321024T1
(de)
*
|
2000-10-17 |
2006-04-15 |
Pharmacia & Upjohn Co Llc |
Verfahren zur herstellung von oxazolidinonverbindungen
|
ATE319710T1
(de)
|
2000-12-21 |
2006-03-15 |
Pharmacia & Upjohn Co Llc |
Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
|
DE10129725A1
(de)
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US6956040B2
(en)
|
2001-07-16 |
2005-10-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone piperazinyl derivatives as potential antimicrobials
|
BR0212458A
(pt)
*
|
2001-09-11 |
2004-10-19 |
Astrazeneca Ab |
Composto ou sal farmaceuticamente aceitável, ou um éster hidrolizável in vivo deste, pró-droga, método para a produção de um efeito antibacteriano em um animal de sangue quente, uso de um composto ou sal farmaceuticamente aceitável, ou um éster hidrolizável in vivo deste, composição farmacêutica, e, processo para a preparação de um composto ou sais farmaceuticamente aceitável, ou ésteres hidrolizáveis in vivo deste
|
AU2002339721A1
(en)
*
|
2002-09-20 |
2004-04-08 |
Lupin Limited |
Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
|
AU2003302404B2
(en)
*
|
2002-11-28 |
2008-06-19 |
Astrazeneca Ab |
Oxazolidinone and / or isoxazoline derivatives as antibacterial agents
|
GB0229521D0
(en)
*
|
2002-12-19 |
2003-01-22 |
Astrazeneca Ab |
Chemical compounds
|
DE10300111A1
(de)
*
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
TW200500360A
(en)
*
|
2003-03-01 |
2005-01-01 |
Astrazeneca Ab |
Hydroxymethyl compounds
|
GB0306358D0
(en)
*
|
2003-03-20 |
2003-04-23 |
Astrazeneca Ab |
Chemical compounds
|
AR044152A1
(es)
|
2003-05-09 |
2005-08-24 |
Bayer Corp |
Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad
|
AU2004267007C1
(en)
*
|
2003-06-03 |
2010-04-29 |
Melinta Subsidiary Corp. |
Biaryl heterocyclic compounds and methods of making and using the same
|
SI1656370T1
(sl)
*
|
2003-06-03 |
2012-12-31 |
Rib-X Pharmaceuticals, Inc. |
Biarilne heterociklične spojine in postopki za njihovo izdelavo in uporabo
|
US8324398B2
(en)
*
|
2003-06-03 |
2012-12-04 |
Rib-X Pharmaceuticals, Inc. |
Process for the synthesis of biaryl oxazolidinones
|
WO2005005420A1
(en)
*
|
2003-07-02 |
2005-01-20 |
Merck & Co., Inc. |
Cyclopropyl group substituted oyazolidinone antibiotics and derivatives thereof
|
JP4607107B2
(ja)
|
2003-07-02 |
2011-01-05 |
メルク・シャープ・エンド・ドーム・コーポレイション |
シクロプロピル基置換されたオキサゾリジノン抗生物質およびこれらの誘導体
|
EP1660465B1
(en)
*
|
2003-07-29 |
2014-12-17 |
Melinta Therapeutics, Inc. |
Process for the synthesis of biaryl oxazolidinones
|
US20070197541A1
(en)
*
|
2003-07-29 |
2007-08-23 |
Oyelere Adegboyega K |
Biaryl heterocyclic amines,amides, and sulfur-containing compounds and methods of making and using the same
|
ES2536001T3
(es)
*
|
2003-07-29 |
2015-05-19 |
Melinta Therapeutics, Inc. |
Procedimiento para la síntesis de biariloxazolidinonas
|
US7411083B2
(en)
|
2003-09-25 |
2008-08-12 |
Wyeth |
Substituted acetic acid derivatives
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
AR046782A1
(es)
*
|
2003-12-17 |
2005-12-21 |
Rib X Pharmaceuticals Inc |
Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.
|
KR100854211B1
(ko)
*
|
2003-12-18 |
2008-08-26 |
동아제약주식회사 |
신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
|
JP2008508271A
(ja)
*
|
2004-07-28 |
2008-03-21 |
リブ−エックス ファーマシューティカルズ,インコーポレイテッド |
ビアリール複素環式化合物ならびにその化合物を製造および使用する方法
|
DE102004062475A1
(de)
*
|
2004-12-24 |
2006-07-06 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
|
EP1685841A1
(en)
*
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention and treatment of thromboembolic disorders
|
WO2006091731A2
(en)
*
|
2005-02-24 |
2006-08-31 |
Teva Pharmaceutical Industries Ltd. |
Processes for the preparation of linezolid intermediate
|
KR101394307B1
(ko)
|
2005-06-08 |
2014-05-13 |
멜린타 테라퓨틱스, 인크. |
트리아졸의 합성 방법
|
DE102005045518A1
(de)
*
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
CA2624310C
(en)
|
2005-10-04 |
2014-01-07 |
Bayer Healthcare Ag |
Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
|
DE102005047558A1
(de)
*
|
2005-10-04 |
2008-02-07 |
Bayer Healthcare Ag |
Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
WO2007102082A1
(en)
*
|
2006-03-09 |
2007-09-13 |
Glenmark Pharmaceuticals Limited |
High oxazolidinone content solid dosage forms
|
WO2007133803A2
(en)
*
|
2006-05-15 |
2007-11-22 |
Rib-X Pharmaceuticals, Inc. |
Treatment of mycobacterial infections
|
CN101522614B
(zh)
|
2006-08-09 |
2014-06-25 |
史密丝克莱恩比彻姆公司 |
作为阿片样物质受体的拮抗剂或反向激动剂的化合物
|
US7666864B2
(en)
|
2008-03-26 |
2010-02-23 |
Global Alliance For Tb Drug Development |
Bicyclic nitroimidazole-substituted phenyl oxazolidinones
|
JPWO2009157423A1
(ja)
*
|
2008-06-24 |
2011-12-15 |
財団法人乙卯研究所 |
縮合環を有するオキサゾリジノン誘導体
|
KR101023174B1
(ko)
*
|
2008-09-24 |
2011-03-18 |
주식회사 레고켐 바이오사이언스 |
사이클릭 아미독심 또는 사이클릭 아미드라존 기를 가지는 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
|
AU2009303301B2
(en)
|
2008-10-10 |
2014-09-11 |
Merck Sharp & Dohme Llc |
Methods for preparing oxazolidinones and compositions containing them
|
KR20170040371A
(ko)
|
2009-02-03 |
2017-04-12 |
머크 샤프 앤드 돔 코포레이션 |
R)-3-(4-(2-(2-메틸테트라졸-5-일)피리딘-5-일)-3-플루오로페닐)-5-히드록시메틸 옥사졸리딘-2-온 디히드로겐 포스페이트의 결정형
|
US8580767B2
(en)
*
|
2009-05-28 |
2013-11-12 |
Trius Therapeutics, Inc. |
Oxazolidinone containing dimer compounds, compositions and methods to make and use
|
KR20130102614A
(ko)
|
2010-11-03 |
2013-09-17 |
욱크하르트 리미티드 |
인산 모노-(1-[4-[(s)-5-(아세틸아미노메틸)-2-옥소-옥사졸리딘-3-일]-2,6-디플루오로페닐]-4-메톡시메틸피페리딘-4-일) 에스테르의 제조 방법
|
CN103896963B
(zh)
*
|
2012-12-26 |
2017-06-09 |
中国科学院上海药物研究所 |
苯并噁嗪噁唑烷酮类化合物及其制备方法和用途
|
ITRM20130155A1
(it)
*
|
2013-03-15 |
2014-09-16 |
I E Me S T Istituto Euro Mediter Raneo Di Scien |
Nuovi composti 1,2,4-ossadiazolici attivi contro patogeni gram-positivi.
|
EP2970244B1
(en)
|
2013-03-15 |
2019-05-29 |
Università Degli Studi Di Milano - Bicocca |
Novel 1, 2, 4-oxadiazol compounds active against gram-positive pathogens
|
US9862710B2
(en)
|
2013-03-15 |
2018-01-09 |
Istituto Euro Mediterraneo Di Scienza E Tecnologia |
1,2,4-oxadiazol compounds active against gram-positive pathogens
|
CN103965183B
(zh)
*
|
2014-03-17 |
2017-05-03 |
上海应用技术学院 |
一种含氟噁唑烷酮类化合物及其制备方法和应用
|
WO2015173664A1
(en)
|
2014-05-14 |
2015-11-19 |
Wockhardt Limited |
Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide
|
WO2017066964A1
(en)
*
|
2015-10-22 |
2017-04-27 |
Merck Sharp & Dohme Corp. |
Oxazolidinone compounds and methods of use thereof as antibacterial agents
|
CN106083994B
(zh)
*
|
2016-04-18 |
2019-12-06 |
南京曼杰生物科技有限公司 |
取代的噁唑烷酮水溶性衍生物及其应用
|